These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3622996)

  • 1. [Parkinson's disease in the elderly: therapeutic note].
    Mantovani M; Bonati PA; Pioli G; Ciotti G; Pedrazzoni M
    G Clin Med; 1987 May; 68(5):303-7. PubMed ID: 3622996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological therapy of complicated Parkinson's disease].
    Jiménez-Jiménez FJ; Molina JA
    Rev Neurol; 1997 Aug; 25 Suppl 2():S170-9. PubMed ID: 9280685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinson's disease.
    Clarke C; Moore A
    Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dangers in drug therapy of Parkinson's disease].
    Gehlen W
    Z Allgemeinmed; 1975 Nov; 51(33):1543-4. PubMed ID: 1210361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug treatment of Parkinson's disease].
    Jansen EN
    Ned Tijdschr Geneeskd; 1986 May; 130(20):897-9. PubMed ID: 3724862
    [No Abstract]   [Full Text] [Related]  

  • 7. Deprenyl in Parkinson's disease.
    Korczyn AD; Nisipeanu P
    Ann Neurol; 1996 Aug; 40(2):268-9. PubMed ID: 8773617
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parkinson disease. Directed use of modern therapy].
    Möller JC; Wächter T; Oertel WH
    MMW Fortschr Med; 2001 May; 143 Suppl 2():45-50. PubMed ID: 11434257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pharmacological and surgical therapies for Parkinson's disease.
    Nutt JG
    West J Med; 1998 Apr; 168(4):267-8. PubMed ID: 9584671
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroprotective agents in Parkinson's disease: clinical evidence and caveats.
    Hälbig TD; Tse W; Olanow CW
    Neurol Clin; 2004 Oct; 22(3 Suppl):S1-S17. PubMed ID: 15501359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parkinson's disease: what therapeutic strategy is advisable in early stage disease?].
    Destee A
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():109-18. PubMed ID: 10916045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Addictions, drives and Parkinson's disease].
    Azulay JP
    Rev Neurol (Paris); 2008 Apr; 164(4):308-9. PubMed ID: 18439922
    [No Abstract]   [Full Text] [Related]  

  • 13. Delusional infestation induced by piribedil add-on in Parkinson's disease.
    Kölle M; Lepping P; Kassubek J; Schönfeldt-Lecuona C; Freudenmann RW
    Pharmacopsychiatry; 2010 Aug; 43(6):240-2. PubMed ID: 20614418
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinson's disease. An overview of treatments and research.
    Tuite PJ
    Minn Med; 2001 May; 84(5):42-7. PubMed ID: 11398632
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa in the treatment of Parkinson's disease: current controversies.
    Gerlach M; Reichmann H; Riederer P
    Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parkinson's disease].
    Jean-Luc H
    Rev Prat; 2005 May; 55(10):1129-34. PubMed ID: 16097259
    [No Abstract]   [Full Text] [Related]  

  • 17. Future therapies for Parkinson's disease.
    Hauser RA; Lyons KE
    Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Parkinson's disease.
    ; ;
    Neurol Sci; 2003 Jun; 24 Suppl 3():S165-213. PubMed ID: 12836051
    [No Abstract]   [Full Text] [Related]  

  • 19. Moderate Parkinson's disease. Strategies for maximizing treatment.
    Silverstein PM
    Postgrad Med; 1996 Jan; 99(1):52-4, 61-3, 67-8, passim. PubMed ID: 8539210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ What drug strategies are advisable for patients with advanced-stage Parkinson's].
    Brefel-Courbon C
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():120-59. PubMed ID: 10916046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.